Carlquist JF - Search Results

1

C-reactive protein predicts death in patients with non-ischemic cardiomyopathy.

Ronnow BS, Reyna SP, Muhlestein JB, Horne BD, Allen Maycock CA, Bair TL, Carlquist JF, Kfoury AG, Anderson JL, Renlund DG; International Heart Collaborative Study Group. Ronnow BS, et al. Among authors: carlquist jf. Cardiology. 2005;104(4):196-201. doi: 10.1159/000088138. Epub 2005 Sep 8. Cardiology. 2005. PMID: 16155394

2

HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-analysis of published HLA association studies.

Carlquist JF, Menlove RL, Murray MB, O'Connell JB, Anderson JL. Carlquist JF, et al. Circulation. 1991 Feb;83(2):515-22. doi: 10.1161/01.cir.83.2.515. Circulation. 1991. PMID: 1825038

3

Increased risk of rejection associated with the growth of lymphocytes from human cardiac allografts.

Carlquist JF, Hammond EH, O'Connell JB, Anderson JL. Carlquist JF, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1146-8. Transplant Proc. 1991. PMID: 1989174 No abstract available.

4

Correlation between class II antigen (DR) expression and interleukin-2-induced lymphocyte proliferation during acute cardiac allograft rejection.

Carlquist JF, Hammond ME, Yowell RL, O'Connell JB, Anderson JL. Carlquist JF, et al. Transplantation. 1990 Oct;50(4):582-8. doi: 10.1097/00007890-199010000-00011. Transplantation. 1990. PMID: 2219279

5

Recovery and phenotypic identification of in vivo-activated lymphocytes from mouse cardiac allografts.

Carlquist JF, Shelby J, Hammond EH, Greenwood JH, Anderson JL. Carlquist JF, et al. Transplantation. 1990 Aug;50(2):349-51. Transplantation. 1990. PMID: 2382303 No abstract available.

6

Propagation and characterization of lymphocytes from rejecting human cardiac allografts.

Carlquist JF, Hammond EH, Anderson JL. Carlquist JF, et al. J Heart Transplant. 1988 Nov-Dec;7(6):397-406. J Heart Transplant. 1988. PMID: 3062146

7

Quantitation of lymphocyte subsets by immunofluorescence flow cytometry in idiopathic dilated cardiomyopathy.

Anderson JL, Carlquist JF, Higashikubo R. Anderson JL, et al. Among authors: carlquist jf. Am J Cardiol. 1985 Jun 1;55(13 Pt 1):1550-4. doi: 10.1016/0002-9149(85)90971-3. Am J Cardiol. 1985. PMID: 3159251

8

Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

Anderson JL, Carlquist JF, Hammond EH. Anderson JL, et al. Among authors: carlquist jf. Lancet. 1982 Nov 20;2(8308):1124-7. doi: 10.1016/s0140-6736(82)92786-6. Lancet. 1982. PMID: 6183539

9

HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors.

Anderson JL, Carlquist JF, Lutz JR, DeWitt CW, Hammond EH. Anderson JL, et al. Among authors: carlquist jf. Am J Cardiol. 1984 May 1;53(9):1326-30. doi: 10.1016/0002-9149(84)90088-2. Am J Cardiol. 1984. PMID: 6585136

10

Correlation between cellular rejection of cardiac allografts and quantitative changes among T-cell subsets identified by V beta epitope expression.

Carlquist JF, Hammond ME, Yowell RL, Holland C, Swanson S, Anderson JL. Carlquist JF, et al. Circulation. 1994 Aug;90(2):686-93. doi: 10.1161/01.cir.90.2.686. Circulation. 1994. PMID: 7519130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters